IN
InvestingNurse
Community Contributor
Member since 2025
Views0Total number of views
Followers0Total number of followers
Comments0Total number of comments
No bio added yet
No link added
Lexaria Bioscience's Breakthrough with DehydraTECH to Revolutionize Drug Delivery
Lexaria Bioscience is testing multiple drug agents using their DehydraTECH (DHT) technology for oral and topical delivery of medications such as GLP-1and CBD. The DehydraTECH is showing substantial improvement in bioabsorption, brain permeation, taste maksing, and side effect reduction.Read more
0
users have viewed this narrative1users have liked this narrative
0users have commented on this narrative
1users have followed this narrative
IN
US$5.55
85.3% undervalued intrinsic discount
InvestingNurse's Fair Value
Revenue
229.79% p.a.
Profit Margin
15.26%
Future PE
22.75x
Price in 2031
US$7.65